Highlights

  • Zycov D likely to be available from October
  • Deemed safe for children above 12 years of age
  • 3 doses with 28 day intervals recommended

Latest news

Karnataka speaker denies minister Patil's conditional resignation

Karnataka speaker denies minister Patil's conditional resignation

Ravi Shastri emphasizes media & tech evolution in cricket

Ravi Shastri emphasizes media & tech evolution in cricket

Proclaimed fugitive Captured After 16 Years in East Delhi

Proclaimed fugitive Captured After 16 Years in East Delhi

Global stock market indices: How the world markets performed today - 02 May 2025

Global stock market indices: How the world markets performed today - 02 May 2025

Indian stock market sector-wise performance today - May 2, 2025

Indian stock market sector-wise performance today - May 2, 2025

NSE Nifty 50: Top 5 stock losers of May 2, 2025

NSE Nifty 50: Top 5 stock losers of May 2, 2025

Top 5 Nifty 50 gainers today – May 2, 2025: Biggest stock moves

Top 5 Nifty 50 gainers today – May 2, 2025: Biggest stock moves

Congress criticizes Modi's remarks at Vizhinjam port event

Congress criticizes Modi's remarks at Vizhinjam port event

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above.”

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Zydus Cadila's covid vaccine ZyCoV-D is set to be launched in India in October and is deemed for safe for kids above 12. This 'third-generation triple dose vaccine' could just be the answer to fill the gap of 100 crore doses required by year-end to vaccinate the vast majority of the adult population. Here is everything you need to know about this non-injecting, DNA vaccine which even children above 12 can take.

      Meet Cadila’s ZyCoV-D

      • It is the world’s first DNA vaccine to protect against Covid 19. Requires a triple dose for immunity and showcased 67% efficacy in trials. The vaccine is deemed safe for children above the age of 12.

      What kind of vaccine is it? How is it different than Covishield and Covaxin?

      • Cadila’s ZyCoV-D is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen like Covaxin.

      How does a DNA vaccine work?

      • Often referred to as the third-generation vaccines, the dose carries the genetic code of the virus that triggers the build up of immunity in one's body.
      • Zydus stated that the plasmid DNA platform is “ideally suited for dealing with Covid-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring”.

      Is a DNA vaccine being used anywhere else in the world?

      • No DNA vaccine has been widely used against any disease so far, but they are more stable and easier to store than mRNA shots (tech used by Pfizer & Moderna)
      • According to the U.S. National Library of Medicine, over 160 different DNA vaccines are currently being tested in human clinical trials in the United States. It is estimated that 62% of these trials are devoted to cancer vaccines and 33% are applied for vaccines against human immunodeficiency virus (HIV).

      How many doses does one need?

      • Unlike most other Covid-19 vaccines, which require two doses for full immunity, ZyCoV-D is administered in three doses. The vaccine is also needle-free.
      • The doses will be administered 28 days apart

      Needle-free vaccine, how does one get the dose?

      • Doses are given using a device that delivers fluid through a spring-powered jet that penetrates the skin, developed by Pharmajet’s Tropis.
      • Zydus Cadila claims this method of delivery is painless and could also reduce side effects from the jab

      Is it safe? What are the trial results showing?

      • The vaccine has been tested on almost 30,000 participants across Phase I, II and III studies, and is the first vaccine in India to be tested on 12 to 18-year-olds. Around 1,000 participants were enrolled in the adolescent age group, among whom the vaccine was found to be safe and well-tolerated, with similar findings in the adult population

      SEBI

      ADVERTISEMENT

      Up Next

      Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

      Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

      Global stock market indices: How the world markets performed today - 02 May 2025

      Global stock market indices: How the world markets performed today - 02 May 2025

      Indian stock market sector-wise performance today - May 2, 2025

      Indian stock market sector-wise performance today - May 2, 2025

      NSE Nifty 50: Top 5 stock losers of May 2, 2025

      NSE Nifty 50: Top 5 stock losers of May 2, 2025

      Top 5 Nifty 50 gainers today – May 2, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – May 2, 2025: Biggest stock moves

      Majority of iPhones sold in US will be made in India in June quarter: Apple CEO

      Majority of iPhones sold in US will be made in India in June quarter: Apple CEO

      ADVERTISEMENT

      editorji-whatsApp

      More videos

      Sensex, Nifty surge in early trade on hopes of India-US trade deal, FII buying

      Sensex, Nifty surge in early trade on hopes of India-US trade deal, FII buying

      Global stock market indices: How the world markets performed today - 01 May 2025

      Global stock market indices: How the world markets performed today - 01 May 2025

      Indian stock market sector-wise performance today - May 1, 2025

      Indian stock market sector-wise performance today - May 1, 2025

      Top 5 Nifty 50 gainers today – May 1, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – May 1, 2025: Biggest stock moves

      Global stock market indices: How the world markets performed today - 30 April 2025

      Global stock market indices: How the world markets performed today - 30 April 2025

      Indian stock market sector-wise performance today - April 30, 2025

      Indian stock market sector-wise performance today - April 30, 2025

      Top 5 Nifty 50 gainers today – April 30, 2025: Biggest stock moves

      Top 5 Nifty 50 gainers today – April 30, 2025: Biggest stock moves

      NSE Nifty 50: Top 5 stock losers of April 30, 2025

      NSE Nifty 50: Top 5 stock losers of April 30, 2025

      Global stock market indices: How the world markets performed today - 29 April 2025

      Global stock market indices: How the world markets performed today - 29 April 2025

      Indian stock market sector-wise performance today - April 29, 2025

      Indian stock market sector-wise performance today - April 29, 2025

      Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.